Potentially orally bioavailable prodrugs of the antiretroviral agent 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) were evaluated. Alkyl methyl carbamates were synthesized by alkylation of PMPA with the corresponding alkyl chloromethyl carbonate and N-alkyl chloromethyl carbamate reagents. The prodrugs were evaluated for in vitro antiviral activity in addition to chemical and enzymic stability. The inhibition of human immunodeficiency virus type 1 (HIV-1) strain IIIB replication in MT-2 cells by the carbonate prodrugs was found to be 2.5-500-fold increased compared to PMPA. The alkyl methyl carbonates, except t-butyl methyl carbonate, had reasonable chemical stability at pH 2.2 and 7.4, but were rapidly converted to the corresponding monoester of PMPA in the presence of dog plasma. The alkyl methyl carbamate prodrugs such as N-t-butyl methyl carbamate were found to have high stability in vitro. Based on its chemical stability and good oral bioavailability, bis(POC)PMPA (isopropyl methyl carbonate) was chosen as a clinical candidate.
AbrahamssonK., ErikssonB.O., HolmeE., JodalU., LindstedtS., & NordinI. (1994) Impaired ketogenesis in carnitine depletion caused by short-term administration of pivalic acid prodrug. Biochemical Medicine and Metabolic Biology52: 18-21.
2.
BalzariniJ, NaesensL., SlachmuyldersJ, NiphuisH., RosenbergI, HolyA., SchellekensH., & De ClercqE. (1991) 9-(2-Phosphonylmethoxy ethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys. AIDS5: 21-28.
3.
BalzariniJ., HolyA., JindrichJ., NaesensL., SnoeckR., ScholsD., & De ClercqE. (1993) Differential antiherpcsvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine. Antimicrobial Agents and Chemotherapy37: 332-338.
4.
BalzariniJ., AquaroS., PernoC-F, WitvrouwM., HolyA., & De ClercqE. (1996) Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxy propyl)adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Biochemical and Biophysical Research Communications219: 337-341.
5.
Barditch-CrovoP., TooleJ., HendrixC.W., CundyK.C., EbelingD., JaffeH.S., and LietmanP.S. (1997) Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics adefovir dipivoxil (9-[2-(bis-pivaloylomethyl)-phosphonomethyoxyethyl]adcnine) in HIV-infected patients (1997)Journal of Infectious Diseases176: 406-413.
6.
BohmeH., & BuddeJ. (1971) Chloromethyl-, Mercaptomethyl- und Imidomethyl-carbonate. Synthesis:588-590.
7.
BransonJ.J., KimC.U., GhazzouliI., HitchcockM.J.M., KernE., & MartinJ.C. (1989) Synthesis and pyrimidine bases. In Nucleosides as Antiviral Agents. Edited by MartinJC. Washington, DC: American Chemical Society, pp. 72-87.
8.
CundyK.C., FishbackJ.A., ShawJ.R., LeeM.L., SoikeK.F., VisorG.C., & LeeW. (1994) Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys. Pharmaceutical Research11: 839-843.
9.
De ClercqE., HolyA., & RosenbergI. (1989) Efficacy of phosphonylmethoxy alkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo. Antimicrobial Agents and Chemotherapy33: 185-191.
10.
EgberinkA., BorstM., NiphuisH., BalzariniJ., NeuH., SchellekensH., De ClercqE., HorzinekM., & KoolenM. (1995) Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonylmethoxyethyl)adenine. Proceedings of National Academy of Sciences, USA87: 3087-3091.
IkedaS., SakamotoF., KondoH., MoriyamaM., & TsukamotoG. (1984) Studies on prodrugs. III. A convenient and practical preparation of ampicillin prodrugs. Chemical and Pharmaceutical Bulletin32: 4316-4322.
13.
IyerR.P., PhillipsL.R., BiddleJ.A., ThakkerD.R., & EganW. (1989) Synthesis of acyloxyalkyl acylphosphonates as potential prodrugs of the antiviral, trisodium phosphonoformate (foscarnet sodium), Tetrahedron Letters30: 7141-7144.
14.
NaesensL., BalzariniJ., BischofbergerN., & De ClercqE. (1996) Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)-adenine. Antimicrobial Agents and Chemotherapy40: 22-28.
15.
PauwelsR., BalzariniJ., ScholsD., BabaM., DesmyterJ., RosenbergI., HolyA., & De ClercqE. (1988) Purine derivatives, a new class of anti-human immunodeficiency virus agents. Antimicrobial Agents and Chemotherapy32: 1025-1030.
16.
SafadiM., OliyaiR., & StellaV.J. (1993) Phosphoryloxymethyl carbamates and carbonates-novel water-soluble prodrugs for amines and hindered alcohols. Pharmaceutical Research10: 1350-1355.
17.
SakamotoF., IkedaS., & TsukamotoG. (1983) Studies on prodrugs. I. Preparation and characterization of acyloxyallylester of ampicillin. Chemical and Pharmaceutical Bulletin31: 2698-2707.
SrivastavaD., & FarquharD. (1984) Bioreversible phosphate protective groups: synthesis and stability of model acyloxymethyl phosphates. Bioorganic Chemistry12: 118-129.
20.
SrinivasR.V., RobbinsB.L., ConnellyM.C., GongY.F., BischofbergerN., & FridlandA. (1993) Metabolism and in vitro antiviral activities of bis(pivaloyloxymethyl)prodrugs of acyclic nucleotide phosphonates. Antimicrobial Agents and Chemotherapy37: 2247-2250.
21.
SrinivasR.V., RobbinsB.L., ConnellyM.C., GongY.F., BischofbergerN., & FridlandA. (1994) Pivaloyloxymethyl esters of acyclic nucleoside phosphonates. International Antiviral News.2: 53-55.
22.
StarrettJ.E.Jr, TortolaniD.R., RussellJ., HitchcockM.J.M., WhiterockV., MartinJ.C., & MansuriM.M. (1994) Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonylmethoxy)ethyl]adenine (PMEA)Journal of Medicinal Chemistry37: 1857-1864.
23.
TsaiC.C., FollisK.E., SaboA., BeckT.W., GrantR.F., BischofbergerN., BenvenisteR.E., & BlackR. (1995) Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science270: 1197-1199.
24.
TsaiC.C., FollisK.E., BeckT.W., SaboA., BischofbergerN., & DaileyP.J. (1997) Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques. AIDS Research and Human Retroviruses13: 707-712.
25.
Van RompayK.K.A., CherringtonJ.M., MarthasM.L., BerardiC.J., MulatoA.S., SpinnerA., TararaR.P., CanfieldD.R., TelmS., BischofbergerN., & PedersonN.C. (1996) 9-[2-(Phosphomethoxy)propyl]-adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrobial Agents and Chemotherapy40: 2586-2591.
26.
WeislowO.S., KiserR., FineD.L., BaderJ., ShoemakerR.H., & BoydM.R. (1989) New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral activity. Journal of the National Cancer Institute81: 577-586.
